Evidence map›Paper›PMID 23913543›Full record

ArticleEukaryotic cell2013

Candida albicans VMA3 is necessary for V-ATPase assembly and function and contributes to secretion and filamentation.

Hallie S Rane, Stella M Bernardo, Summer M Raines, Jessica L Binder, Karlett J Parra, Samuel A Lee

Open access · diamondAbstract read
In one paragraph

Article in Eukaryotic cell, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. The V-ATPase VJournal of oral microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Candida albicansMicrobiology spectrum · 2022
    Article
  8. Article
  9. Phytochemical Screening and In Vitro Antifungal Activity of Selected Medicinal Plants againstAdvances in pharmacological and pharmaceutical sciences · 2022
    Article
  10. Article
  11. Candida albicansmSphere · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. The Role of Secretory Pathways inJournal of fungi (Basel, Switzerland) · 2020
    Review
  16. Article
  17. Frontiers in microbiology · 2019
    Article
  18. Article
  19. Promising Antifungal Targets AgainstFrontiers in cellular and infection microbiology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hallie S RaneSection of Infectious Diseases, New Mexico Veterans Healthcare System, Albuquerque, New Mexico, USA.
Stella M Bernardo
Summer M Raines
Jessica L Binder
Karlett J Parra
Samuel A Lee
University of New Mexico · USNew Mexico VA Health Care System · US

Funding

FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
V-ATPase H+ PUMP REGULATION IN FUEL ENERGY SELECTIONR01GM086495 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI PARRA, KARLETT J · 2009 to 2013
$1.7M
NIAID NIH HHS 5 T32 AI007538-13NIAID NIH HHS T32 AI007538NIGMS NIH HHS 5R01GM086495NIGMS NIH HHS K12 GM088021NIGMS NIH HHS K12GM088021NIGMS NIH HHS R01 GM086495
6 · The paper itself

Abstract

The vacuolar membrane ATPase (V-ATPase) is a protein complex that utilizes ATP hydrolysis to drive protons from the cytosol into the vacuolar lumen, acidifying the vacuole and modulating several key cellular response systems in Saccharomyces cerevisiae. To study the contribution of V-ATPase to the biology and virulence attributes of the opportunistic fungal pathogen Candida albicans, we created a conditional mutant in which VMA3 was placed under the control of a tetracycline-regulated promoter (tetR-VMA3 strain). Repression of VMA3 in the tetR-VMA3 strain prevents V-ATPase assembly at the vacuolar membrane and reduces concanamycin A-sensitive ATPase-specific activity and proton transport by more than 90%. Loss of C. albicans V-ATPase activity alkalinizes the vacuolar lumen and has pleiotropic effects, including pH-dependent growth, calcium sensitivity, and cold sensitivity. The tetR-VMA3 strain also displays abnormal vacuolar morphology, indicative of defective vacuolar membrane fission. The tetR-VMA3 strain has impaired aspartyl protease and lipase secretion, as well as attenuated virulence in an in vitro macrophage killing model. Repression of VMA3 suppresses filamentation, and V-ATPase-dependent filamentation defects are not rescued by overexpression of RIM8, MDS3, EFG1, CST20, or UME6, which encode positive regulators of filamentation. Specific chemical inhibition of Vma3p function also results in defective filamentation. These findings suggest either that V-ATPase functions downstream of these transcriptional regulators or that V-ATPase function during filamentation involves independent mechanisms and alternative signaling pathways. Taken together, these data indicate that V-ATPase activity is a fundamental requirement for several key virulence-associated traits in C. albicans.

Indexed as

ExocytosisProtein MultimerizationAspartic Acid ProteasesCandida albicansFungal ProteinsLipaseMutationVacuolar Proton-Translocating ATPasesVacuolesVirulenceAspartic Acid ProteasesFungal ProteinsLipaseVacuolar Proton-Translocating ATPases

Identifiers

PMID23913543
PMCPMC3811332
OpenAlexW2141515471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.